LinusBio, a genomics data-powered precision medicine company providing virtual treatment for gastrointestinal disorders, raised $16 million in Series A funding.
GreatPoint Ventures and Bow Capital led the investment round with participation from Divergent Investments, Nicole Shanahan (President, Bia-Echo Foundation), the David Bellet Family Office, Gillian Sandler, and Sanford Robertson (Co-Founder of Francisco Partners and former board member of Salesforce).
With new funds, LinusBio aims to transform how complex disorders are diagnosed and treated – from autism to gastrointestinal disorders to amyotrophic lateral sclerosis to renal disease and cancers. These complex disorders lack biological tests to aid in the diagnosis, monitor progression or serve as objective endpoints in clinical trials, the company said in a statement. The company’s platform can help identify novel compounds for health conditions where genomic biomarkers have previously had limited success. The company is already using its platform in two pharma-sponsored trials and is in the process of partnering with several organizations within the healthcare and pharma ecosystem.
“Our mission is simple: to deliver better outcomes for people and families affected by complex health conditions,” said Manish Arora, Co-founder and CEO of LinusBio.
“We chose to focus on autism first for many considerations, an important one of them is the dramatically different trajectory in cases of an early detection and effective intervention. The impact on the patient and the patient’s family can be substantial. We’re proud to launch the LinusBio platform to meet the tremendous need for better, faster, and comprehensive diagnostics and treatments for a range of conditions and diseases,” added Manish Arora.
Precision medicine startups
According to our funding database, digital precision medicine startups have secured more than $2 billion in funding to date. The latest funding rounds in precision medicine include:
L7 Informatics, a provider of AI-guided precision medicine software for life sciences and healthcare organizations, raised $38 million in funding led by Banneker Partners with follow-on investment from returning investors.
Endpoint Health secured $52 million in Series A funding to grow its precision medicine platform that uses AI to help doctors make better clinical decisions.
Click here to read more about the latest digital health funding news…
